NCT00791765View on ClinicalTrials.gov

Moderate to Severe Plaque Psoriasis With Scalp Involvement

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
Psoriasis
Interventions
BIOLOGICAL

Etanercept

Etanercept for subcutaneous injection.

BIOLOGICAL

Placebo

Placebo for subcutaneous injection.

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00791765 - Moderate to Severe Plaque Psoriasis With Scalp Involvement | Biotech Hunter | Biotech Hunter